Navigation Links
Kalam Dedicates New Cancer Drug Developed By Biocon

President A P J Abdul Kalam today dedicated to the nation India's first indigenously developed drug for treating head and neck cancer. //

Kalam congratulated Biocon scientists for developing the monoclonal antibody, BioMab EGFR (epidermal growth factor receptor), which company officials said works by binding to cancer cell-specific antigens and inducing an immunological response against the target cell.

Bangalore-based Biocon's chairperson Kiran Mazumdar-Shaw said the 'life-saving cancer drug' will hit the market in the next few months.

Company executives said though a large number of monoclonal antibodies have been launched in the country, they are beyond the reach of a majority of cancer patients because of their prohibitive cost.

They said Biocon's new drug will be effective in several types of cancer that express EGFR, including colo-rectal, pancreatic, metastatic breast, non small cell lung and brain cancers.

'BIOMab EGFR is indicated for use in combination with radiation therapy or chemotherapy in patients with positive expression of EGFR in squamous cell carcinoma of head and neck cancer,' the company said.

Kalam also inaugurated Biocon Park, the country's largest integrated bio-tech hub comprising an integrated cluster of laboratories and manufacturing facilities.

Built with a total investment of Rs 650 crore on a 90-acre plot, the park is the single largest capital investment made by Biocon in its 27-year history.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. Abdul Kalam Confident of AIDS vaccine on Indian market soon
2. Kalam Appeals to Eradicate Hearing Disability
3. Kalam To Lay Foundation Of Vellore Research Center
4. President Kalam Meets Striking Medicos However Stir to Continue
5. President Kalam Meets Striking Medicos However Stir to Continue
6. Abdul Kalam Moved by Orissa Topper’s Eye Disorde
7. Eye Hospital Founder a Beacon Light for Ophthalmologists: Kalam
8. Disabled Girl Urges Kalam to Intervene Against the Denial of Admission
9. Teachers are Creators of Enlightened Citizens in the Country- Dr. A.P.J Abdul Kalam
10. Kalams Intervention Brings Hope to Orissa Student
11. Autistic Children Need Sense of Equality: A.P.J. Abdul Kalam
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...in women years in advance of a medical diagnosis o...demiologists at the University at Buffalo in New Y...for diabetes found in the blood, such as markers o...-acute inflammation and blood clotting factors, ar...
... diet pill under the brand name Alli, there has be...ng down their weight. Alli has been given the stat...s drug is said to block the absorption of fat by t...se stools are reported to be the side effects of A...
... found to bring down the androgen levels in women....emirel University in Isparta, Turkey. Hirsutism i...excessive hair in the face, breasts and stomach in...ed level of male hormone, androgen which is respon...
...death of 16 persons who were infected by the bacte... at a hospital near Montreal .An investigation las...orely missing at the hospital, where even three in...re a single bed. The bacteria C. difficile has be...
Other Medicine News:Health News:Diabetes Risk Factors Develop Earlier in Women Than Men 2
(Date:9/3/2008)...Australia, Sept. 4 /Xinhua-...aq: PXSL) today announced,that it has enrolled the...nical trial evaluating Bronchitol in cystic fibros...ed in 41 hospitals across North,America, Argentina...e,Pharmaxis seeks approval to market Bronchitol fo...
(Date:9/3/2008)...erm follow up results from chronically infected He...itive data obtained earlier in 2008, - Study is ...long-term antiviral effect of therapeutic H...strongly support move into a second generation, v...) acting through TLR ...
(Date:9/3/2008)...sis showed that Multaq(R) (dronedarone) decreased ...ibrillation or atrial flutter already ...IDGEWATER, N.J., Sept. 3 /-...om the ATHENA study were presented today at,the cl...y of Cardiology,congress 2008, in Munich, Germany....
(Date:9/3/2008)...to be Evaluated in Repeat-Dosing Study in Subjects...FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq: ...2 clinical trial (SB-509-801) to evaluate its drug...enerative motor-neuron disease for which there,are...s drug, SB-509, is an injectable formulation of a ...
Breaking Medicine Technology:Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5NFL Themed Milk Touches Down in Schools and Retail Grocery Stores 1555 1NFL Themed Milk Touches Down in Schools and Retail Grocery Stores 1555 2NFL Themed Milk Touches Down in Schools and Retail Grocery Stores 1555 3MAKO Surgical Corp Files Registration Statement for Initial Public Offering of Common Stock 670 1MAKO Surgical Corp Files Registration Statement for Initial Public Offering of Common Stock 670 2The International Diabetes Federation 28IDF 29 Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes 668 1The International Diabetes Federation 28IDF 29 Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes 668 2The International Diabetes Federation 28IDF 29 Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes 668 3Misconceptions about Alzheimers varies among races survey suggests 451 1Misconceptions about Alzheimers varies among races survey suggests 451 2
...NGTON--(BUSINESS WIRE)--May 21, 2007 - Roche today...that all patients who,discontinued treatment with ...n due to adverse events within the first 12 weeks,...PEGASYS(R),(peginterferon alfa-2a) and ribavirin. ...e to go on and complete a full course of,treatment...
...ED DOSE COMBINATION WITH DIURETIC ACCEPTED FOR REV... NJ, 21 May 2007 -,Speedel (SWX: SPPN) today welco...ls of SPP100 (aliskiren, Tekturna/Rasliez[1]),pres...ic Meeting,and Exposition of the American Society ...esults confirm the favourable safety and,efficacy ...
Other Medicine Technology:Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 2Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 3Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 4Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 5Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 6New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 2New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 3New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 4New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 5New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 6New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 7New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 8New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 9New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 10New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 11
Inquire
...lly inspects your equipment upon arrival. Our tech...d provides you with a thorough customer quote. We ...get so well help you prioritize repairs. With cust...., , ISI uses only OEM or widely approved equi...
The Infinity™ ALT single liquid stable reagent is intended for the in vitro quantitative determination of ALT in serum. , Infinity™ ALT reagent patented formulation not only provides ex
...owder reagent is intended for the in vitro quantit...ALT (GPT) powder reagent patented formulation not ...ed and convenience, but ensures excellent precisio...gent is suitable for manual use or on automated cl...
Medicine Products: